子宫内膜取样对子宫内膜癌诊断的准确性:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE、EMBASE、ClinicalTrials.gov和Cochrane图书馆(自建库至2017年1月1日),纳入45项研究(12,459例患者),比较术前子宫内膜取样与子宫切除标本在肿瘤分级和组织学亚型上的一致性。肿瘤分级的合并一致率为0.67(95%CI 0.60-0.75),Cohen's κ为0.45(95%CI 0.34-0.55);宫腔镜活检一致率高于诊刮,但与诊室子宫内膜活检无显著差异。
要点
- 肿瘤分级合并一致率0.67(95%CI 0.60-0.75),Cohen's κ 0.45(95%CI 0.34-0.55)。
- 宫腔镜活检一致率0.89高于诊刮0.70(P=.02),与诊室活检0.73无显著差异(P=.08)。
- 2级癌一致率最低,为0.61(95%CI 0.53-0.69)。
核心结论
- 术前子宫内膜取样与最终诊断在肿瘤分级上仅为中等一致性,其中2级癌的一致性最低。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、ClinicalTrials.gov和Cochrane图书馆,检索时间自建库至2017年1月1日。
- 纳入45项研究,共12,459例患者;索引试验为诊室子宫内膜活检、宫腔镜活检或刮宫,参考标准为子宫切除标本。
- 由两名独立评价者评估纳入资格,并采用诊断准确性研究质量评价工具(Quality Assessment of Diagnostic Accuracy Studies)评估偏倚风险。
主要发现
- 肿瘤分级的合并一致率为0.67(95%CI 0.60-0.75),Cohen's κ为0.45(95%CI 0.34-0.55)。
- 宫腔镜活检与最终诊断的一致率为0.89(95%CI 0.80-0.98),高于刮宫的0.70(95%CI 0.60-0.79;P=.02);与诊室子宫内膜活检的0.73(95%CI 0.60-0.86)相比无显著差异(P=.08)。
- 2级癌的一致率最低,为0.61(95%CI 0.53-0.69)。
- 25%的子宫内膜样本出现降级,21%出现升级。
- 组织学亚型一致率:术前子宫内膜样癌为0.95(95%CI 0.94-0.97),非子宫内膜样癌为0.81(95%CI 0.69-0.92)。
关键数值与推荐
- 肿瘤分级合并一致率0.67(95%CI 0.60-0.75),Cohen's κ 0.45(95%CI 0.34-0.55)。
- 宫腔镜活检一致率0.89(95%CI 0.80-0.98) vs 刮宫0.70(95%CI 0.60-0.79),P=.02。
- 宫腔镜活检一致率0.89(95%CI 0.80-0.98) vs 诊室子宫内膜活检0.73(95%CI 0.60-0.86),P=.08,无显著差异。
- 2级癌一致率0.61(95%CI 0.53-0.69)。
- 组织学亚型一致率:子宫内膜样癌0.95(95%CI 0.94-0.97),非子宫内膜样癌0.81(95%CI 0.69-0.92)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the agreement between preoperative endometrial sampling and final diagnosis for tumor grade and subtype in patients with endometrial carcinoma. DATA SOURCES: MEDLINE, EMBASE, ClinicalTrials.gov, and the Cochrane library were searched from inception to January 1, 2017, for studies that compared tumor grade and histologic subtype in preoperative endometrial samples and hysterectomy specimens. METHODS OF STUDY SELECTION: In eligible studies, the index test included office endometrial biopsy, hysteroscopic biopsy, or dilatation and curettage; the reference standard was hysterectomy. Outcome measures included tumor grade, histologic subtype, or both. TABULATION, INTEGRATION, AND RESULTS: Two independent reviewers assessed the eligibility of the studies. Risk of bias was assessed (Quality Assessment of Diagnostic Accuracy Studies). A total of 45 studies (12,459 patients) met the inclusion criteria. The pooled agreement rate on tumor grade was 0.67 (95% CI 0.60-0.75) and Cohen's κ was 0.45 (95% CI 0.34-0.55). Agreement between hysteroscopic biopsy and final diagnosis was higher (0.89, 95% CI 0.80-0.98) than for dilatation and curettage (0.70, 95% CI 0.60-0.79; P=.02); however, it was not significantly higher than for office endometrial biopsy (0.73, 95% CI 0.60-0.86; P=.08). The lowest agreement rate was found for grade 2 carcinomas (0.61, 95% CI 0.53-0.69). Downgrading was found in 25% and upgrading was found in 21% of the endometrial samples. Agreement on histologic subtypes was 0.95 (95% CI 0.94-0.97) and 0.81 (95% CI 0.69-0.92) for preoperative endometrioid and nonendometrioid carcinomas, respectively. CONCLUSION: Overall there is only moderate agreement on tumor grade between preoperative endometrial sampling and final diagnosis with the lowest agreement for grade 2 carcinomas.
引用
- Visser NCM, Reijnen C, Massuger LFAG, et al. Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis. Obstet Gynecol. 2017. PMID: 28885397. doi:10.1097/AOG.0000000000002261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。